UnknownNot Applicable

Voice Rest and Injection Laryngoplasty

United States150 participantsStarted 2023-08-01

Plain-language summary

The purpose of this study is to evaluate the subjective, objective, and aerodynamic impact of voice rest following injection augmentation and compare the outcomes to patients with no post-procedure voice restrictions.

Who can participate

Age range18 Years – 89 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age \>18 years old
✓. Undergoing injection augmentation by Dr. McGarey, Dr. Torrecillas, or Dr. Daniero for the following conditions:
✓. Glottic insufficiency from atrophy, scar, or presbylarynx
✓. Unilateral or bilateral vocal fold immobility
✓. Unilateral or bilateral vocal fold hypomobility

Exclusion criteria

✕. Prior history of head and neck radiation.
✕. Active or recent (within 3 months) chemotherapy.
✕. Age \<18 years old
✕. Incarcerated individuals will be excluded due to inability to enroll in post-intervention clinic visit
✕. Presence of posterior glottic stenosis
✕. Presence of acute laryngeal injury
✕. Bedside inpatient injection augmentation
✕. Vocal fold Injection with steroids or cidofovir

What they're measuring

Patient-perceived voice improvement

Timeframe: 2 weeks

Trial details

NCT IDNCT05542550

SponsorUniversity of Virginia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-31

Contact for this trial

James J Daniero, MD

4349242040 jjd5h@uvahealth.org

View on ClinicalTrials.gov More Vocal Cord Paralysis trials